Stopping GLP-1 Drugs May Raise Heart Attack Risk, Especially in Medically Obese Patients

A recent study indicates that discontinuing GLP-1 drugs could increase the risk of heart attacks, particularly among individuals classified as medically obese. The risk appears to be higher for this group compared to those of normal weight. This finding highlights the importance of careful management when stopping these medications.

Originally published by gnews